ACYLAMIDE COMPOUNDS HAVING SECRETAGOGUE OR INDUCER ACTIVITY OF ADIPONECTIN
    7.
    发明申请
    ACYLAMIDE COMPOUNDS HAVING SECRETAGOGUE OR INDUCER ACTIVITY OF ADIPONECTIN 失效
    具有ADIPONECTIN的秘密活性或诱导活性的酰亚胺化合物

    公开(公告)号:US20070282002A1

    公开(公告)日:2007-12-06

    申请号:US11835029

    申请日:2007-08-07

    IPC分类号: A61K31/198 C07C235/12

    摘要: The present invention provides an acylamide compound of the following formula (1), prodrugs thereof, or pharmaceutically acceptable salts thereof; and an adiponectin inducer or secretagogue, therapeutic agent of metabolic syndromes, therapeutic agent of hypoadiponectinemia, therapeutic agent of hyperlipemia, preventive/therapeutic agent of diabetes, improving agent of impaired glucose tolerance, improving agent of insulin resistance, enhancing agent of insulin sensitivity, therapeutic agent of hypertension, preventive/therapeutic agent of vascular disorders, an anti-inflammatory agent, therapeutic agent of hepatic inflammation, therapeutic agent of fatty liver, therapeutic agent of hepatic fibrosis, therapeutic agent of liver cirrhosis, preventive/therapeutic agent of non-alcoholic/nonviral steatohepatitis (NASH) or non-alcoholic/nonviral fatty liver disease (NAFLD), or therapeutic agent of obesity, each of which has the above compounds as an active ingredient.

    摘要翻译: 本发明提供下式(1)的酰胺化合物,其前体药物或其药学上可接受的盐; 和脂联素诱导剂或促分泌素,代谢综合征的治疗剂,低脂联素血症的治疗剂,高脂血症的治疗剂,糖尿病的预防/治疗剂,葡萄糖耐量降低的改善剂,胰岛素抵抗的改善剂,胰岛素敏感性的增强剂,治疗 高血压药物,血管疾病的预防/治疗剂,抗炎剂,肝脏炎症治疗剂,脂肪肝治疗剂,肝纤维化治疗剂,肝硬化治疗剂,非酒精性预防/治疗剂 /非病毒性脂肪性肝炎(NASH)或非酒精性/非病毒性脂肪性肝病(NAFLD)或肥胖症治疗剂,其各自具有上述化合物作为活性成分。

    Acylamide compounds having secretagogue or inducer activity of adiponectin
    8.
    发明授权
    Acylamide compounds having secretagogue or inducer activity of adiponectin 失效
    具有促分泌素或脂联素诱导活性的酰胺化合物

    公开(公告)号:US07732637B2

    公开(公告)日:2010-06-08

    申请号:US11835029

    申请日:2007-08-07

    IPC分类号: C07C229/06 A61K31/20

    摘要: The present invention provides an acylamide compound of the following formula (1), prodrugs thereof, or pharmaceutically acceptable salts thereof; and an adiponectin inducer or secretagogue, therapeutic agent of metabolic syndromes, therapeutic agent of hypoadiponectinemia, therapeutic agent of hyperlipemia, preventive/therapeutic agent of diabetes, improving agent of impaired glucose tolerance, improving agent of insulin resistance, enhancing agent of insulin sensitivity, therapeutic agent of hypertension, preventive/therapeutic agent of vascular disorders, an anti-inflammatory agent, therapeutic agent of hepatic inflammation, therapeutic agent of fatty liver, therapeutic agent of hepatic fibrosis, therapeutic agent of liver cirrhosis, preventive/therapeutic agent of non-alcoholic/nonviral steatohepatitis (NASH) or non-alcoholic/nonviral fatty liver disease (NAFLD), or therapeutic agent of obesity, each of which has the above compounds as an active ingredient.

    摘要翻译: 本发明提供下式(1)的酰胺化合物,其前体药物或其药学上可接受的盐; 和脂联素诱导剂或促分泌素,代谢综合征的治疗剂,低脂联素血症的治疗剂,高脂血症的治疗剂,糖尿病的预防/治疗剂,葡萄糖耐量降低的改善剂,胰岛素抵抗的改善剂,胰岛素敏感性的增强剂,治疗 高血压药物,血管疾病的预防/治疗剂,抗炎剂,肝脏炎症治疗剂,脂肪肝治疗剂,肝纤维化治疗剂,肝硬化治疗剂,非酒精性预防/治疗剂 /非病毒性脂肪性肝炎(NASH)或非酒精性/非病毒性脂肪性肝病(NAFLD)或肥胖症治疗剂,其各自具有上述化合物作为活性成分。

    Glass plate conveying device and beveling apparatus including the same
    9.
    发明授权
    Glass plate conveying device and beveling apparatus including the same 有权
    玻璃板输送装置和包括其的斜面装置

    公开(公告)号:US09296080B2

    公开(公告)日:2016-03-29

    申请号:US13876051

    申请日:2011-03-24

    摘要: The present invention provides a conveying device including a transfer mechanism including: a belt portion configured to support a non-pattern surface of a glass plate and transfer the glass plate in a conveying direction; and a pattern surface supporting water guide arranged at a position opposed to the belt portion and configured to apply predetermined water pressure to a pattern surface of the glass plate, wherein the transfer mechanism is configured such that: the glass plate is pressed against the belt portion by water pressure of the pattern surface supporting water guide; and the glass plate is sandwiched between the pattern surface supporting water guide and the belt portion in a state where the pattern surface of the glass plate is in a non-contact state, the conveying device being capable of stably transferring the glass plate without making scratches on the pattern surface of the glass plate.

    摘要翻译: 本发明提供一种包括传送机构的传送装置,包括:皮带部,其构造成支撑玻璃板的非图案表面并在输送方向上传送玻璃板; 以及布置在与所述带部分相对的位置处并构造成对所述玻璃板的图案表面施加预定水压的图案表面支撑水引导件,其中所述传送机构构造成:所述玻璃板被压靠在所述带部分上 通过图案表面支撑导水器的水压; 并且在玻璃板的图案表面处于非接触状态的状态下,玻璃板被夹在图案表面支撑水引导件和带部分之间,输送装置能够稳定地转移玻璃板而不产生划痕 在玻璃板的图案表面上。

    Electric motor control apparatus and electric supercharging apparatus using electric motor control apparatus
    10.
    发明授权
    Electric motor control apparatus and electric supercharging apparatus using electric motor control apparatus 有权
    电动机控制装置和使用电动机控制装置的电动增压装置

    公开(公告)号:US09212602B2

    公开(公告)日:2015-12-15

    申请号:US13465440

    申请日:2012-05-07

    摘要: An electric motor control apparatus includes a phase correction portion that generates and outputs an amount of phase correction with which to correct a phase of a signal from a position sensor detecting a position of a magnetic pole of an electric motor. The phase correction portion generates and outputs an energization stop signal in a case where a rotation speed of the electric motor is within a predetermined range and stores an amount of phase correction generated therein according to a comparison between a signal from the position sensor or a first phase and an induced voltage of the electric motor to output the amount of phase correction.

    摘要翻译: 电动机控制装置包括:相位校正部,其生成并输出相位校正量,用于校正来自检测电动机的磁极位置的位置传感器的信号的相位。 在电动机的转速在预定范围内的情况下,相位校正部分产生并输出通电停止信号,并根据来自位置传感器的信号或第一 相和电动机的感应电压输出相位校正量。